Gene delivery and gene therapy with herpes simplex virus-based vectors
- 1 February 2001
- Vol. 264 (1) , 1-9
- https://doi.org/10.1016/s0378-1119(01)00322-5
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Heat Shock Proteins Delivered With a Virus Vector Can Protect Cardiac Cells Against Apoptosis As Well As Against Thermal or Hypoxic StressJournal of Molecular and Cellular Cardiology, 1999
- Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometryGene Therapy, 1998
- Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson diseaseProceedings of the National Academy of Sciences, 1997
- Double Transduction with GTP Cyclohydrolase I and Tyrosine Hydroxylase Is Necessary for Spontaneous Synthesis ofl-DOPA by Primary FibroblastsJournal of Neuroscience, 1996
- Over-expression of heat shock protein 70 protects neuronal cells against both thermal and ischaemic stress but with different efficienciesNeuroscience Letters, 1996
- Long-Term Behavioral Recovery in Parkinsonian Rats by an HSV Vector Expressing Tyrosine HydroxylaseScience, 1994
- In Vivo Expression of β-Galactosidase in Hippocampal Neurons by HSV-Mediated Gene TransferHuman Gene Therapy, 1992
- A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neuronsNeuron, 1990
- Construction and characterization of a herpes simplex virus type 1 mutant unable to transinduce immediate-early gene expressionJournal of Virology, 1989
- Latent Herpes Simplex Virus in Human Trigeminal GangliaNew England Journal of Medicine, 1987